Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2001
11/21/2001EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001EP1155007A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
11/21/2001EP1155006A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
11/21/2001EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001EP0917555B1 Electrochrome system
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001CN1323305A An improved process for the preparation of thiazolidine-2,4-dione derivatives
11/21/2001CN1323304A 2-hetaryl-3,4-dihydro-2h-pyrrole derivatives
11/21/2001CN1323297A Pyridazinone derivatives
11/21/2001CN1322719A MYT1 kinase inhibitor
11/21/2001CN1075074C Sulfonyl azaleneone compound
11/21/2001CN1075072C Oxazolidinone derivatives their preparation and use
11/21/2001CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/20/2001US6320057 Reacting 2-thiothiazolidine-5-ones with an optionally acylated aryl- or heteroaryl-hydrazine
11/20/2001US6320054 Thiazole derivatives
11/20/2001US6320047 Substituted aryl or heteroarylamides having retinoid-like biological activity
11/20/2001US6320045 Process for the reduction of oxiranyl epothilones to olefinic epothilones
11/20/2001US6319940 Carbanilides used as pesticides
11/20/2001US6319939 Retinoic acid mimetic anlides
11/20/2001US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001US6319933 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives; fungicides
11/20/2001US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/15/2001WO2001085760A1 Thrombin inhibitors
11/15/2001WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001WO2001085726A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001WO2001085723A1 Gastrin and cholecystokinin receptor ligands (ii)
11/15/2001WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001WO2001085720A1 Novel anti-infectives
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085709A2 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
11/15/2001WO2001085707A1 Para-amine substituted phenylamide glucokinase activators
11/15/2001WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001WO2001085693A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001WO2001085172A1 Novel anti-infectives
11/15/2001WO2001085146A1 Pharmaceutical compounds for treating copd
11/15/2001WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001WO2001032652A3 N-substituted carbamoyloxyalkyl-azolium derivatives
11/15/2001WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001US20010041728 With thiourea, thioamide, or dithiocarbamate functionality; (S)-N-(((3-(3-fluoro-4-morpholinyl)phenyl)-2-oxo-5 -oxazolidinyl)methyl)thioacetamide for example; treats multiple-resistant staphylococci
11/15/2001US20010041723 Using agonists and antagonists of the nicotinergic acetylcholine receptors of insects such as fleas, lice and flies, on humans and animals
11/15/2001US20010041715 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/15/2001US20010041691 (Dihydrogen phosphonoxy)alkyloxy containing a triazole derivative used as antifungal agent
11/15/2001DE19954230A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408448A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408293A1 Novel vitronectin receptor antagonists
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001CA2406512A1 Pharmaceutical compounds for treating copd
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001EP0885212B1 Quinoxalinediones
11/14/2001EP0828721B1 2-amino-benzoxazinones for the treatment of viral infections
11/14/2001EP0675882B1 5-aryl-1,3-thiazine derivatives, manufacture thereof and use as pesticides
11/14/2001CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001CN1322203A Heterocyclyl amino methyloxazolidinones as antibacterials
11/14/2001CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001CN1074764C Benzoxazinone dopamine D4 receptor antagonists
11/13/2001US6316635 Used in prophylaxis and therapy of protein kinase related cellular disorders such as cancer, diabetes, autoimmune disorder, hyperproliferation disorder, inflammatory disorder, angiogenesis, restenosis, fibrosis, psoriasis, osteoarthritis
11/13/2001US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001US6316451 Heterocyclyl anthracyclinone derivatives
11/13/2001US6316442 Treatment of heart disease and cerebrovascular disturbances
11/13/2001US6315384 Thermal inkjet printhead and high-efficiency polycrystalline silicon resistor system for use therein
11/08/2001WO2001083800A2 Heterologous production of polyketides
11/08/2001WO2001083478A2 Hydantoin-containing glucokinase activators
11/08/2001WO2001083473A1 Process for producing optically active sulfoxide derivative
11/08/2001WO2001083472A1 Muscarinic agonists
11/08/2001WO2001083469A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001WO2001083465A2 Alkynyl phenyl heteroaromatic glucokinase activators
11/08/2001WO2001083460A1 Cyclic compounds
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001WO2001082873A2 A medicinal aerosol formulation
11/08/2001WO2001056567A8 2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
11/08/2001WO2001044242A9 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
11/08/2001WO2001029012A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001US20010039353 Water soluble prodrugs of azole compounds
11/08/2001US20010039350 Suitable for prophylaxis of diseases involving interleukin-1 beta such as septic shock, leukemia, hepatits, muscular degeneration, HIV infections, or degenerative joint diseases
11/08/2001US20010039289 Antagonists; especially sodium salts
11/08/2001US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001US20010039275 Use of 2,4-diaminothiazole derivatives
11/08/2001US20010039273 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
11/08/2001CA2407796A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001CA2407594A1 Muscarinic agonists
1 ... 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 ... 628